{"transactions":[{"id":1171903,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":80787,"kind":"person","name":"Scheessele William John","position":1,"cik":"0001879378","reported_name":"Scheessele William John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-04-15T16:03:35.000Z","date":"2025-04-14","kind":"purchase","planned":false,"acquired":true,"shares":6493,"price":1.54,"value":9999.22,"ownership":{"direct":true},"balance_after":22018,"source":{"system":"sec-edgar","filing":"0001818382-25-000052","document":"wk-form4_1744747408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1879378/000181838225000052/wk-form4_1744747408.xml","form_type":"4"}},{"id":1296534,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":80787,"kind":"person","name":"Scheessele William John","position":1,"cik":"0001879378","reported_name":"Scheessele William John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-01-23T16:34:58.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":283101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on January 21, 2026, after which 1/48 of the option will become exercisable on the 21st of each month through  January 21, 2029."}],"balance_after":283101,"derivative":{"exercise_price":4.56,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":283101},"source":{"system":"sec-edgar","filing":"0001818382-25-000020","document":"wk-form4_1737668091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1879378/000181838225000020/wk-form4_1737668091.xml","form_type":"4"}},{"id":1714568,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":80787,"kind":"person","name":"Scheessele William John","position":1,"cik":"0001879378","reported_name":"Scheessele William John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-12-12T16:10:32.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":276000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on December 8, 2024, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2027."}],"balance_after":276000,"derivative":{"exercise_price":2.8,"expiration_date":"2033-12-08","underlying":"Common Stock","underlying_shares":276000},"source":{"system":"sec-edgar","filing":"0001818382-23-000197","document":"wk-form4_1702415423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1879378/000181838223000197/wk-form4_1702415423.xml","form_type":"4"}},{"id":2085308,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":80787,"kind":"person","name":"Scheessele William John","position":1,"cik":"0001879378","reported_name":"Scheessele William John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-12-15T19:53:54.000Z","date":"2022-12-13","kind":"purchase","acquired":true,"shares":5000,"price":3.09,"value":15450.0,"ownership":{"direct":true},"balance_after":15525,"source":{"system":"sec-edgar","filing":"0001818382-22-000212","document":"wf-form4_167115202101303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1879378/000181838222000212/wf-form4_167115202101303.xml","form_type":"4"}},{"id":2089941,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":80787,"kind":"person","name":"Scheessele William John","position":1,"cik":"0001879378","reported_name":"Scheessele William John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-12T16:15:15.000Z","date":"2022-12-08","kind":"grant","acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026."}],"balance_after":136000,"derivative":{"exercise_price":3.07,"expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001818382-22-000201","document":"wf-form4_167087968780298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1879378/000181838222000201/wf-form4_167087968780298.xml","form_type":"4"}},{"id":2256924,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":80787,"kind":"person","name":"Scheessele William John","position":1,"cik":"0001879378","reported_name":"Scheessele William John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-05-25T11:46:58.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":10525,"price":4.72,"value":49678.0,"ownership":{"direct":true},"balance_after":10525,"source":{"system":"sec-edgar","filing":"0001818382-22-000053","document":"wf-form4_165349360232953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1879378/000181838222000053/wf-form4_165349360232953.xml","form_type":"4"}},{"id":2541821,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":80787,"kind":"person","name":"Scheessele William John","position":1,"cik":"0001879378","reported_name":"Scheessele William John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-10-15T15:51:53.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":157558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on August 9, 2022, after which 1/36 of the option will become exercisable on the 9th of each month through August 9, 2025."}],"balance_after":157558,"derivative":{"exercise_price":10.03,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":157558},"source":{"system":"sec-edgar","filing":"0001104659-21-126728","document":"tm2130120-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1879378/000110465921126728/tm2130120-7_4seq1.xml","form_type":"4"}}]}